76-57-3 Usage
Description
Different sources of media describe the Description of 76-57-3 differently. You can refer to the following data:
1. Codein phosphate and hydrochloride caused contact
dermatitis in a worker in the production of opium
alkaloids. Codeine bitartrate caused contact dermatitis
in a worker in the production of concentrated poppy
straw. Codeine was a sensitizer in a laboratory worker
at an opiate-manufacturing pharmaceutical company,
also sensitive to the baine.
2. Codeine (CRM) (Item No. ISO60140) is a certified reference material categorized as an opioid. Like other opioid analgesics, codeine is commonly abused. Codeine is regulated as a Schedule II compound in the United States. Codeine (CRM) (Item No. ISO60140) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
Chemical Properties
Different sources of media describe the Chemical Properties of 76-57-3 differently. You can refer to the following data:
1. White Solid
2. Codeine, also known as methylmorphine, C18H21NO3· H2O, is a colorless white crystalline substance, slightly soluble in water, soluble in alcohol and chloroform, effloresces slowly in dry air.
Uses
Different sources of media describe the Uses of 76-57-3 differently. You can refer to the following data:
1. Codeine is derived from opium by extraction or by the methylation of morphine. For medical use, codeine is usually offered as the dichloride, phosphate, or sulfate. Codeine is habit forming. Codeine is known to exacerbate urticaria (familiarly known as hives). Since codeine is incorporated in numerous prescription medicines for headache, heartburn, fatigue, coughing, and relief of aches and pains, persons with a history of urticaria should make this fact known to their physician. Codeine is sometimes used in cases of acute pericarditis to relieve severe chest pains in early phases of disease. Codeine is sometimes used in drug therapy of renal (kidney) diseases.
2. Codeine is used in medicine for its narcoticanalgesic action. It is used as a sedative incough mixtures. Codeine occurs in opiumfrom 0.7% to 2.5%. It is prepared frommorphine by methylating the phenolic OHgroup of the morphine. It is also obtained byextraction of opium.
Definition
Different sources of media describe the Definition of 76-57-3 differently. You can refer to the following data:
1. ChEBI: A morphinane alkaloid found in the opium poppy, Papaver somniferum var. album; has analgesic, anti-tussive and anti-diarrhoeal properties.
2. codeine: An alkaloid C18H21NO3found in opium. It is structurally similarto morphine, from which it isproduced, and is used in the form ofthe sulphate or phosphate as apainkiller and cough medicine.Codeine is converted into morphinein the liver. It is used to some extentas a recreational drug. In the UK it isa class B drug but can be obtained incomposite over-the-counter preparationsin which it has a low concentrationand is combined with paracetamolor ibuprofen. See also opioids.
Brand name
Algisedal;Codol;Diarrest;Novacetol;Sedarene.
World Health Organization (WHO)
Codeine, which has antitussive, opioid analgesic and antidianhoeal
activity, was first extracted from opium in 1832 and has since been widely used in
medicine. The development of dependence and its potential for abuse resulted in
the control af the substance under Schedule II of the 1961 Single Convention on
Narcotic Drugs. Preparations containing codeine remain widely available and are
included in the WHO Model List of Essential Drugs.(Reference: (WHTAC1) The Use of Essential Drugs, 2nd Report of the WHO Expert
Committee, 722, , 1985)
Biological Functions
Like morphine, codeine is a naturally occurring opioid
found in the poppy plant. Codeine is indicated for the
treatment of mild to moderate pain and for its antitussive
effects. It is widely used as an opioid antitussive because
at antitussive doses it has few side effects and has
excellent oral bioavailability. Codeine is metabolized in
part to morphine, which is believed to account for its
analgesic effect. It is one of the most commonly used
opioids in combination with nonopioids for the relief of
pain. The administration of 30 mg of codeine in combination
with aspirin is equivalent in analgesic effect to
the administration of 65 mg of codeine. The combination
of the drugs has the advantage of reducing the amount of opioid required for pain relief and abolition
of the pain via two distinct mechanisms, inhibition of
prostanoid synthesis and opioid inhibition of nociceptive
transmission. When given alone, orally administered
codeine has about one-tenth to one-fifth the potency
of morphine for the relief of pain. In addition, IV
codeine has a greater tendency to release histamine and
produce vasodilation and hypotension than does morphine.
Thus, the use of IV codeine is rare. Codeine is
rarely addictive and produces little euphoria.
General Description
Different sources of media describe the General Description of 76-57-3 differently. You can refer to the following data:
1. Codeine is an alkaloid that occurs naturally in opium, butthe amount present is usually too small to be of commercialimportance. Consequently, most commercial codeine is preparedfrom morphine by methylating the phenolic OHgroup. It occurs as levorotatory, colorless, efflorescent crystals,or as a white crystalline powder. It is light sensitive.Codeine is a monoacidic base and readily forms salts withacids, with the most important being the sulfate and thephosphate. The acetate and methylbromide derivatives havebeen used to a limited extent in cough preparations.The general pharmacological action of codeine is similarto that of morphine, but it does not possess the sameanalgesic potency.
2. Colorless to white crystalline solid or white powder. Sublimes at 284°F. Odorless. Bitter taste. pH (saturated aqueous solution) 9.8.
Air & Water Reactions
CODEINE is light sensitive and sensitive to prolonged exposure to air. Insoluble in water.
Reactivity Profile
CODEINE is incompatible with bromides, iodides and salts of heavy metals. . CODEINE is an amine. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.
Hazard
Habit-forming narcotic, sale legally
restricted.
Health Hazard
The toxic effects due to codeine are similarbut less toxic than those of morphineand other opium alkaloids. An overdosecan cause respiratory failure. It is a weakdepressant of the central nervous system.It also exhibits stimulant action. Toxicsymptoms from high dosages may includedrowsiness, sleep, tremors, excitement, andhallucinations. It may also produce gastricpains and constipation. An oral LD50 value in rats is 427 mg/kg. The habit-forming effectsof codeine are lower than those associatedwith morphine.Nagamatsu and coworkers (1985) havereported in vitro formation of codeinonefrom codeine by rat or guinea pig liverhomogenate. Codeinone may be a metabolicintermediate in the presence of nicotinamideadenine dinucleotide (NAD). Its acute toxicityin mice was determined to be 30 timeshigher than that of codeine.
Fire Hazard
CODEINE is combustible.
Pharmacology
Codeine is a constituent of opium. Up to 10% of a dose of codeine is
metabolised by the hepatic microsomal enzyme CYP2D6 to morphine, which
contributes significantly to its analgesic effect. The rest is metabolised in the
liver to norcodeine and then conjugated to produce glucuronide conjugates
of codeine, norcodeine and morphine. Codeine is considerably less potent
than morphine. A round 8% of Western Europeans are deficient in the
CYP2D6 enzyme and may not experience adequate analgesia with codeine.
S imilarly, with super-metabolisers, there may be problems with opioid
toxicity; particular care is needed in the breastfeeding mother as morphine is
transferred in milk. Codeine can cause significant histamine release, and
intravenous administration should be avoided. It has marked antitussive
effects and also causes significant constipation. It is often combined with
paracetamol.
Purification Methods
Codeine crystallises from water or aqueous EtOH. Dry it at 80o. Evaporation of a CHCl3 extract gives a colourless glass which crystallises on scratching. It crystallises from H2O as the monohydrate, m 157-158.5o, and has [] D -136o (c 2.8, EtOH). The hydrobromide crystallises in needles from H2O, and effervesces at 151-160o, solidifies and remelts with extensive decomposition at 273-278o. It sublimes at 100o/0.03mm. [Gates J Am Chem Soc 75 4340 1953, Dauben et al. J Org Chem 44 1567 1979, Beilstein 27 II 136, 27 III/IV 2228.]
Check Digit Verification of cas no
The CAS Registry Mumber 76-57-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 7 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 76-57:
(4*7)+(3*6)+(2*5)+(1*7)=63
63 % 10 = 3
So 76-57-3 is a valid CAS Registry Number.
InChI:InChI=1/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1
76-57-3Relevant articles and documents
Enantioselective synthesis of (-)-codeine and (-)-morphine
Trost, Barry M.,Tang, Weiping
, p. 14542 - 14543 (2002)
A new synthetic strategy for the synthesis of the opiate and amaryllidaceae alkaloids emerges employing a Pd-catalyzed asymmetric allylic alkylation to set the stereochemistry. The pivotal tricyclic intermediate is available in six steps from 2-bromovanillin and the monoester of methyl 6-hydroxycyclohexene-1-carboxylate, the latter available from glutaraldehyde and the Emmons-Wadsworth-Horner phosphate reagent. This intermediate requires only two steps to convert to (-)-galanthamine. Using a Heck vinylation, we found that the fourth ring of codeine/morphine is formed. The final ring formation involves a novel visible light-promoted hydroamination. Thus, six steps are required to convert the pivotal tricyclic intermediate into codeine, which has been demethylated in high yield to morphine. Copyright
BIOTRANSFORMATION OF CODEINONE TO CODEINE BY IMMOBILIZED CELLS OF PAPAVER SOMNIFERUM
Furuya, Tsutomu,Yoshikawa, Takafumi,Taira, Megumi
, p. 999 - 1002 (1984)
Papaver somniferum (opium poppy) cells were immobilized in calcium alginate, where they continued to live with their biological activity for 6 months.The immobilized living cells performed the biotransformation of (-)-codeinone to (-)-codeine in both a shake flask and a column bioreactor.The biotransformation ratio in the shake flask (70.4percent) was higher than that in the cell suspension (60.8percent).Furthermore, 88percent of the codeine converted was extracted in the medium.The column bioreactor was functional for 30 days under optimal conditions (20 deg C, 3,75 vvm in aeration), whereas the ratio was 41.7percent.Key Word Index - Papaver somniferum; Papaveraceae; immobilized cell; biotransformation; bioreactor; codeinone; codeine; GC/MS; SIM.
Total Synthesis of Codeine
Li, Qilin,Zhang, Hongbin
, p. 16379 - 16382 (2015/11/09)
In this paper, a new strategy towards the synthesis of codeine and morphine is reported. This new approach features a cascade cyclization to construct the dihydrofuran ring, and an intramolecular palladium catalyzed C-H olefination of unactivated aliphatic alkene to install the morphinan ring system.
Polonovski-type N-demethylation of N-methyl alkaloids using substituted ferrocene redox catalysts
Kok, Gaik B.,Scammells, Peter J.
experimental part, p. 2587 - 2594 (2012/09/22)
Various substituted ferrocenes have been trialed as catalysts in the nonclassical Polonovski reaction for N-demethylation of N-methyl alkaloids. Earlier studies suggest that conditions facilitating a higher ferrocenium ion concentration lead to superior outcomes. In this regard, the bifunctional ferrocene FcCH2CO2H, with electron donor and acceptor moieties in the same molecule, has been shown to be advantageous for use as a catalyst in the N-demethylation of a number of tertiary N-methylamines such as codeine, thebaine, and oripavine. These substrates are readily N-demethylated under mild conditions, employing sub-stoichiometric amounts of the substituted ferrocene at ambient temperature. These reactions are equally efficient in air and may also be carried out in one pot. Georg Thieme Verlag Stuttgart · New York.
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.